ESTRADIOL 25MG PELLETS 1 PELLET, 15 PEL, 15 PELLET, 2 PELLET, 2 TAB, 3 PELLET, 4 PELLET, 6 PELL, 6 PELLET; ESTRADIOL 50MG PELLETS 1 PELELT, 1 PELLET, 4 PELLET, 6 PELLET; ESTRADIOL CYPIONATE 5MG/ML INJECTABLE 5 ML; ESTRADIOL VALERATE IN COTTONSEED OIL 40 MG/ML INJECTABLE 10 ML; ESTRADIOL VALERATE IN SESAME OIL 40 MG/ML INJECTABLE 10 ML (16 DIFFERENT PRODUCTS)

Class I - Dangerous

What Should You Do?

  1. Check if you have this product:
    Rx #'s: 0389464 0398833 0399748 0402917 0402926 0405892 0404079 0404086 0392875 0398067 0403137 0403795 0404506 0408694 0404895 0387492 0389813 0390461 0391264 0391818 0391961 0392952 0393766 0395543 0396232 0396925 0397181 0397313 0397959 0399219 0400227 0400749 0400845 0401497 0401998 0402465 0402997 0403162 0405298 0405330 0405341 0406903 0407419 0408021 0409309 0409791 0402406 0402414 0389982 0389976 0407175 0386101 0391782 0394584 0399576 0403154 0403358 0404795 0406532 0409701 0410127 0400234 0389894 0369509 0407537 0387936 0388504 0401671 0391774 0395019
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Franck's Lab Inc., d.b.a. Franck's Compounding Lab
Reason for Recall:
Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

ESTRADIOL 25MG PELLETS 1 PELLET, 15 PEL, 15 PELLET, 2 PELLET, 2 TAB, 3 PELLET, 4 PELLET, 6 PELL, 6 PELLET; ESTRADIOL 50MG PELLETS 1 PELELT, 1 PELLET, 4 PELLET, 6 PELLET; ESTRADIOL CYPIONATE 5MG/ML INJECTABLE 5 ML; ESTRADIOL VALERATE IN COTTONSEED OIL 40 MG/ML INJECTABLE 10 ML; ESTRADIOL VALERATE IN SESAME OIL 40 MG/ML INJECTABLE 10 ML (16 DIFFERENT PRODUCTS)

Product Codes/Lot Numbers:

Rx #'s: 0389464 0398833 0399748 0402917 0402926 0405892 0404079 0404086 0392875 0398067 0403137 0403795 0404506 0408694 0404895 0387492 0389813 0390461 0391264 0391818 0391961 0392952 0393766 0395543 0396232 0396925 0397181 0397313 0397959 0399219 0400227 0400749 0400845 0401497 0401998 0402465 0402997 0403162 0405298 0405330 0405341 0406903 0407419 0408021 0409309 0409791 0402406 0402414 0389982 0389976 0407175 0386101 0391782 0394584 0399576 0403154 0403358 0404795 0406532 0409701 0410127 0400234 0389894 0369509 0407537 0387936 0388504 0401671 0391774 0395019

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-1515-2012

Related Recalls

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

May 21, 2012 Compounded Drugs Nationwide View Details →

LISSAMINE GREEN SOLUTION 1% OPHTHALMIC 10 ML (1 PRODUCT)

Franck's Lab Inc., d.b.a. Franck's Compounding Lab

Class I - Dangerous

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

May 21, 2012 Other Drugs Nationwide View Details →

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

May 25, 2012 Compounded Drugs Nationwide View Details →